Psoriasis Oral Therapy Update: Report From the AAD Meeting

Dr. Gary Goldenberg presented on oral therapies for psoriasis at the summer meeting of the American Academy of Dermatology. He reviews the clinical trial data for apremilast and JAK inhibitors such as tofacitinib. Dr. Goldenberg also discusses oral experimental therapies that may be on the horizon, such as fumarates, which are used in Europe and will soon be undergoing trials in the United States.